Kristin Stephens, Chief Development Officer at Syros Pharmaceuticals, Inc. (SYRS), sold 36,133 shares at $0.22 ($8K) on 2024-11-18, disclosed to the SEC on 2024-11-20.
Open-market sale of $8k SYRS by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.